Latest News from Chronic Disease Epidemiology

A research team led by Dr. Nicola Hawley, PhD, hopes its findings will lead to a better future for gestational diabetes screening recommendations and treatment.

Scholar-at-Risk Eman Salih says her time at YSPH has been defined by the expansion of ideas, partnerships, and hope.

A longitudinal study published in JAMA NetworkOpen sought to explore quality of care among patients who are incarcerated or recently released and compare their outcomes with those of the general population. One of the study authors, Cary P. Gross, MD, discussed the background for this study in an interview with CancerNetwork.

A new study led by Yale’s Jennifer Miller, PhD, found that medicines are not physically accessible in many of the countries where they are tested for FDA approval.

A study by YSPH Professor Michaela Dinan and colleagues finds that for older, long-term cancer survivors, age, comorbidities, and prior cardiovascular disease events, and not chemotherapy, were the primary drivers of late cardiovascular disease events.

YSPH Adjunct Professor Susan Mayne, former director of the FDA’s Center for Food Safety and Applied Nutrition, is alarmed by a dramatic drop in American inspections of foreign food facilities that supply the U.S. market.

A new Yale study investigates the quality of cancer care among those diagnosed with cancer during or immediately after incarceration.

YSPH's Dr. Melinda Irwin, PhD, MPH, discusses the association between excess weight and breast cancer and how metabolic changes driven by GLP-1 medications such as Ozempic or Zepbound may help reduce risk.